High-performance liquid chromatographic procedure for the determination of a new anti-gastric ulcer agent, 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propioni c acid, in human plasma and urine.
Shioya
Y
Y
Department of Drug Metabolism, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Japan.
Shimizu
T
T
D000409:Alanine / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000652:urine; D000897:Anti-Ulcer Agents / Q000097:blood / Q000378:metabolism* / Q000652:urine; D055598:Chemical Phenomena; D002621:Chemistry; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D008297:Male; D015363:Quinolones / Q000097:blood / Q000378:metabolism* / Q000652:urine; D013050:Spectrometry, Fluorescence
D000897:Anti-Ulcer Agents; D015363:Quinolones; C052785:rebamipide; D000409:Alanine